Tissue inhibition of angiotensin-converting enzyme activity stimulates angiogenesis in vivo: a potential downside.
Goldstein
M R
MR
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects*; D000818:Animals; D000075202:Contraindications; D006614:Hindlimb / Q000098:blood supply; D006801:Humans; D007511:Ischemia / Q000378:metabolism / Q000503:physiopathology; D009369:Neoplasms / Q000098:blood supply / Q000150:complications; D009389:Neovascularization, Pathologic; D018919:Neovascularization, Physiologic / Q000187:drug effects*; D009928:Organ Specificity; D011817:Rabbits
D000806:Angiotensin-Converting Enzyme Inhibitors